One study on
subclinical hypothyroidism patients (no symptoms) showed a 360 percent increased risk in developing overt hypothyroidism, with increased TSH and reduced T4 levels.
Using readily - available registry data, we were able to examine a large population and compare treated versus untreated
subclinical hypothyroidism patients with respect to all - cause mortality.»
During follow up, 1,566 of
the subclinical hypothyroidism patients died.
The team now plan to examine the effect of levothyroxine medication on a subset of
subclinical hypothyroidism patients who also have heart conditions in more detail.
«Our main finding was that levothyroxine treatment had no effect on overall death rates in
subclinical hypothyroidism patients.
Not exact matches
Research Fellow, Mette Andersen, who led the study, said, «This is the largest population - based study to examine whether levothyroxine treatment for
patients with
subclinical hypothyroidism can affect their mortality.
«Thyroid medication has no effect on death rates in
patients with
subclinical hypothyroidism.»
12,212 (1.9 %)
patients were diagnosed with
subclinical hypothyroidism.
Subclinical hypothyroidism is a mild form of underactive thyroid disease where
patients have raised levels of thyroid stimulating hormone (TSH) but a normal concentration of free thyroid hormone.
Additionally, most
patients feel so much better when they start on thyroid hormones when they have
subclinical hypothyroidism.
Based on thyroid biochemistry, the 39
patients were subclassified into euthyroidism in ten (5 %; 95 % CI 2 - 9),
subclinical hypothyroidism in seven (3.8 %; 95 % CI 1.8 - 7.6), and overt
hypothyroidism (Hashimoto's thyroiditis) in 22 (12 %; 95 % CI 8 - 16).
Treatment with zinc improved thyroid function and reduced the incidence of
subclinical hypothyroidism in
patients with Down syndrome, who have an increased risk of
hypothyroidism (6).
However, in euthyroid
patients with Hashimoto's thyroiditis, this escape phenomenon from the inhibitory effect of iodine is impaired, resulting in
subclinical or clinical
hypothyroidism (10).
RESULTS: Seven
patients in the iodine - treated group developed
subclinical hypothyroidism and one
patient became hypothyroid.
This study discovered administering T4 to
patients with «high - normal» TSH (2 - 4 uIU / mL) lowered their cholesterol, supporting the existence of a
subclinical hypothyroidism with tangible harms, and numerous citing papers argue for a narrower reference range.
A
subclinical hypothyroidism mean that the
hypothyroidism is active but the
patient itself doesn't feel anything wrong or doesn't feel any signs and symptoms of having the disease.
The positive rate and concentrations of IgG3 in the
patients with
hypothyroidism were significantly higher than those of
subclinical autoimmune thyroiditis (P < 0.05).
We studied 23
patients with goiter due to Hashimoto's thyroiditis; 10 had clinical
hypothyroidism (CH) and 13 had
subclinical hypothyroidism (SH).
Seven
patients in the iodine - treated group developed
subclinical hypothyroidism and one
patient became hypothyroid.
As
patients, it is essential to understand the reality of
subclinical hypothyroidism and recognize the importance of having it properly treated.
Even if a
patient does not recognize symptoms associated with
subclinical hypothyroidism, optimization of the thyroid can be a revelatory and life - changing experience.
Researchers in the study evaluated untreated
patients with
subclinical hypothyroidism along with
patients taking a T4 hormone.